What the FDA labels say about taking them together
Bevacizumab and epinephrine
Bevacizumab's FDA label of March 23, 2026 names epinephrine in its warnings and precautions section; the epinephrine labels PlainMeds reads (4) do not name bevacizumab.
Check it at the source: the bevacizumab FDA label on DailyMed (effective March 23, 2026, Amneal Pharmaceuticals LLC); the epinephrine FDA label on DailyMed (effective July 13, 2026, A-S Medication Solutions).
What does the bevacizumab label say about epinephrine?
Bevacizumab label, warnings and precautionsDiscontinue in patients who develop a severe infusion-related reaction and administer appropriate medical therapy (e.g., epinephrine, corticosteroids, intravenous antihistamines, bronchodilators and/or oxygen).
Source: FDA drug label (ALYMSYS), Amneal Pharmaceuticals LLC, effective March 23, 2026 (SPL set 6b4040a2-a5c5-4ff0-ab45-935d7e49cf78), via openFDA; the full label on DailyMed
What does the epinephrine label say about bevacizumab?
Epinephrine's label (effective July 13, 2026) and its 3 other brand-application labels do not name bevacizumab in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Epinephrine), A-S Medication Solutions, effective July 13, 2026 (SPL set 6e811e28-0199-4df7-a916-5940c632401d), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Bevacizumab | Epinephrine | |
|---|---|---|
| Labeled for | Colorectal cancer, Lung cancer | Asthma |
| Boxed warning | No | No |
| Pharmacy cost (NADAC) | n/a | $123.51 per unit 0.15 mg auto-injct |
| Shortage now | No current entry | A presentation being discontinued |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once